Eosinophilic Granulomatosis With Polyangiitis Clinical Trial
Official title:
A Single-arm/Randomized, Double-blind, Placebo-controlled, Parallel-group Phase 2/3 Clinical Study to Evaluate the Efficacy and Safety of SHR-1703 for Patients With EGPA
This study is a phase 2/3 clinical trial to evaluate the efficacy and safety of SHR-1703 in patients with EGPA.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT02967068 -
VCRC Tissue Repository
|
||
| Recruiting |
NCT05030155 -
Study of Mepolizumab-based Regimen Compared to Conventional Therapeutic Strategy in Patients With Eosinophilic Granulomatosis With Polyangiitis (E-merge)
|
Phase 3 | |
| Active, not recruiting |
NCT03164473 -
Maintenance of Remission With Rituximab Versus Azathioprine for Newly-diagnosed or Relapsing Eosinophilic Granulomatosis With Polyangiitis.
|
Phase 3 | |
| Recruiting |
NCT05263934 -
Efficacy and Safety of Depemokimab Compared With Mepolizumab in Adults With Relapsing or Refractory Eosinophilic Granulomatosis With Polyangiitis (EGPA)
|
Phase 3 | |
| Recruiting |
NCT02006134 -
Pediatric Vasculitis Initiative
|
||
| Recruiting |
NCT06046222 -
Trial of Efficacy and Safety of NS-229 Versus Placebo in Patients With Eosinophilic Granulomatosis With Polyangiitis
|
Phase 2 | |
| Completed |
NCT04280601 -
PRagmatic Analysis of Vitamin D in ANCA-Associated Vasculitis
|
N/A | |
| Not yet recruiting |
NCT06231498 -
The Epigenomic Signature of Eosinophilic Granulomatosis With Polyangiitis
|
||
| Recruiting |
NCT00315380 -
Longitudinal Study for Eosinophilic Granulomatosis With Polyangiitis
|
||
| Completed |
NCT03298061 -
Long-term Access Program (LAP) of Mepolizumab for Subjects Who Participated in Study MEA115921
|
Phase 3 |